V020-7767 Screening compound: 3-tert-butyl-4-(3-fluorophenyl)-1-(4-fluorophenyl)-8-[2-(morpholin-4-yl)-2-oxoethyl]-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-7-one

V020-7767 Screening compound: 3-tert-butyl-4-(3-fluorophenyl)-1-(4-fluorophenyl)-8-[2-(morpholin-4-yl)-2-oxoethyl]-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-7-one
V020-7767 Screening compound: 3-tert-butyl-4-(3-fluorophenyl)-1-(4-fluorophenyl)-8-[2-(morpholin-4-yl)-2-oxoethyl]-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-7-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-7767
3-tert-butyl-4-(3-fluorophenyl)-1-(4-fluorophenyl)-8-[2-(morpholin-4-yl)-2-oxoethyl]-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-7-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-7767

Molecular Formula

C28H30F2N4O3S (C28 H30 F2 N4 O3 S)

Compound Name

3-tert-butyl-4-(3-fluorophenyl)-1-(4-fluorophenyl)-8-[2-(morpholin-4-yl)-2-oxoethyl]-1H,4H,6H,7H,8H-pyrazolo[3,4-e][1,4]thiazepin-7-one

IUPAC name

3-tert-butyl-4-(3-fluorophenyl)-1-(4-fluorophenyl)-8-[2-(morpholin-4-yl)-2-oxoethyl]-1H4H6H7H8H-pyrazolo[34-e][14]thiazepin-7-one

SMILES

CC(C)(C)c(c(C(c1cc(F)ccc1)SC1)c2N(CC(N3CCOCC3)=O)C1=O)nn2-c(cc1)ccc1F

InChI

InChI=1S/C28H30F2N4O3S/c1-28(2,3)26-24-25(18-5-4-6-20(30)15-18)38-17-23(36)33(16-22(35)32-11-13-37-14-12-32)27(24)34(31-26)21-9-7-19(29)8-10-21/h4-10,15,25H,11-14,16-17H2,1-3H3/t25-/m1/s1

InChI Key

HOPZBTFJMJPGBU-RUZDIDTESA-N

MDL Number (MFCD)

MFCD19793775

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

540.63

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.438

Distribution Coefficient, logD

4.438

Water Solubility, LogSw

-4.30

Polar Surface Area

54.597

Acid Dissociation Constant (pKa)

21.40

Base Dissociation Constant (pKb)

-1.65

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.30

V020-7767 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with V020-7767 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-7767?
Check Price and Availability of V020-7767, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-7767 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-7767
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-7767
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-7767 available by request